Skip to content
10-Q

Quarterly Report

RUBIUS THERAPEUTICS, INC.

0001709401-22-000014

← back to feed
Filed
Aug 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 29, 2022 90.36M sh
Shares Diluted Q2 2022 · Jun 30, 2022 90.26M sh
Shares Diluted Q2 2022 · Jun 30, 2022 90.2M sh
Shares Diluted Q2 2022 · Jun 30, 2021 89.52M sh
Shares Diluted Q2 2022 · Jun 30, 2021 85.94M sh
Capex Q2 2022 · Jun 30, 2022 $4.17M
Capex Q2 2022 · Jun 30, 2021 $1.59M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$81.42M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$73.46M
Long Term Debt Q2 2022 · Jun 30, 2022 $76.6M
Long Term Debt Q2 2022 · Dec 31, 2021 $76.15M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $62.21M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $225.85M
Stockholders Equity Q2 2022 · Jun 30, 2022 $95.54M
Stockholders Equity Q2 2022 · Mar 31, 2022 $134.65M
Stockholders Equity Q2 2022 · Dec 31, 2021 $178.78M
Stockholders Equity Q2 2022 · Jun 30, 2021 $264.11M
Stockholders Equity Q2 2022 · Mar 31, 2021 $300.98M
Stockholders Equity Q2 2022 · Dec 31, 2020 $141.56M
Current Liabilities Q2 2022 · Jun 30, 2022 $30.99M
Current Liabilities Q2 2022 · Dec 31, 2021 $34.66M
Total Liabilities Q2 2022 · Jun 30, 2022 $133.54M
Total Liabilities Q2 2022 · Dec 31, 2021 $139.24M
Current Assets Q2 2022 · Jun 30, 2022 $143.49M
Current Assets Q2 2022 · Dec 31, 2021 $229.82M
Total Assets Q2 2022 · Jun 30, 2022 $229.08M
Total Assets Q2 2022 · Dec 31, 2021 $318.02M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.49
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.07
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.56
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.08
Eps Basic Q2 2022 · Jun 30, 2022 −$0.49
Eps Basic Q2 2022 · Jun 30, 2022 −$1.07
Eps Basic Q2 2022 · Jun 30, 2021 −$0.56
Eps Basic Q2 2022 · Jun 30, 2021 −$1.08
Sga Expense Q2 2022 · Jun 30, 2022 $9.91M
Sga Expense Q2 2022 · Jun 30, 2022 $22.47M
Sga Expense Q2 2022 · Jun 30, 2021 $13.85M
Sga Expense Q2 2022 · Jun 30, 2021 $27.09M
Rd Expense Q2 2022 · Jun 30, 2022 $33M
Rd Expense Q2 2022 · Jun 30, 2022 $71.3M
Rd Expense Q2 2022 · Jun 30, 2021 $36.07M
Rd Expense Q2 2022 · Jun 30, 2021 $63.75M
Net Income Q2 2022 · Jun 30, 2022 −$44.24M
Net Income Q2 2022 · Jun 30, 2022 −$96.65M
Net Income Q2 2022 · Mar 31, 2022 −$52.41M
Net Income Q2 2022 · Jun 30, 2021 −$50.18M
Net Income Q2 2022 · Jun 30, 2021 −$92.51M
Net Income Q2 2022 · Mar 31, 2021 −$42.33M
Operating Income Q2 2022 · Jun 30, 2022 −$42.91M
Operating Income Q2 2022 · Jun 30, 2022 −$93.77M
Operating Income Q2 2022 · Jun 30, 2021 −$49.92M
Operating Income Q2 2022 · Jun 30, 2021 −$90.84M
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $0